Abstracts tagged "patient questionnaires and vasculitis"

Abstract Number: 2639 • 2019 ACR/ARP Annual Meeting
Comparison of Patient Self-reported Data to Physician-driven Cohorts in Patients with Eosinophilic Granulomatosis with Polyangiitis
Irena Doubelt¹, Jason Springer ², Tanaz Kermani ³, Antoine Sreih ⁴, Cristina Burroughs ⁵, David Cuthbertson ⁵, Simon Carette ¹, Nader A. Khalidi ⁶, Curry L. Koening ⁷, Carol Langford ⁸, Carol A. McAlear ⁹, Larry W. Moreland ¹⁰, Paul Monach ¹¹, Dianne Shaw ¹², Philip Seo ¹³, Ulrich Specks ¹⁴, Kalen Young ¹⁵, Steven Ytterberg ¹⁴, Peter A. Merkel ¹⁶, Christian Pagnoux ¹ and VCRC Vasculitis Clinical Research Consortium ¹⁷, ¹Mount Sinai Hospital and University Health Network, Toronto, ON, Canada, ²Kansas University Medical Center, Kansas, MO, ³University of California Los Angeles, Los Angeles, CA, ⁴University of Pennsylvania, Philadelphia, PA, ⁵University of South Florida, Tampa, FL, ⁶McMaster University, Hamilton, ON, Canada, ⁷University of Utah Hospital, Salt Lake City, UT, ⁸Cleveland Clinic, Cleveland, OH, ⁹University of Pennsylvania - VCRC Project Manager, Philadelphia, PA, ¹⁰University of Pittsburgh, Pittsburgh, PA, ¹¹Brigham and Women's Hospital, Boston, MA, ¹²Vasculitis Foundation, North Carolina, ¹³Johns Hopkins Medicine, Baltimore, MD, ¹⁴Mayo Clinic College of Medicine, Rochester, MN, ¹⁵Vasculitis Foundation, Kansas City, MO, ¹⁶Univeristy of Pennsylvania, Philadelphia, PA, ¹⁷University of Pennsylvania, Division of Rheumatology, philadelphia
Background/Purpose: Aligning perspectives of patients and physicians in the diagnosis and management of diseases is imperative, particularly in rare, chronic diseases such as vasculitis. We…
Abstract Number: 1526 • 2012 ACR/ARHP Annual Meeting
Patient Reported Outcomes in ANCA-Associated Vasculitis. A Prospective Comparison Between Birmingham Vasculitis Activity Score and Routine Assessment of Patient Index Data 3
Osama ElSallabi¹, Joel A. Block¹ and Antoine Sreih², ¹Section of Rheumatology, Rush University Medical Center, Chicago, IL, ²Medicine/Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: ANCA-associated vasculitis (AAV) is a rare group of diseases comprising Granulomatosis with polyangiitis (Wegener’s; GPA), Microscopic Polyangiitis (MPA), and Churg-Strauss Syndrome (CSS). These diseases…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].